Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Century Therapeutics (IPSC) Tax Provisions (2022 - 2024)

Century Therapeutics (IPSC) has disclosed Tax Provisions for 3 consecutive years, with $1.8 million as the latest value for Q4 2024.

  • Quarterly Tax Provisions rose 304.37% to $1.8 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2024, down 4.38% year-over-year, with the annual reading at $5000.0 for FY2025, 99.72% down from the prior year.
  • Tax Provisions for Q4 2024 was $1.8 million at Century Therapeutics, up from -$8000.0 in the prior quarter.
  • The five-year high for Tax Provisions was $1.8 million in Q4 2024, with the low at -$869000.0 in Q4 2023.
  • Average Tax Provisions over 3 years is $312500.0, with a median of $23500.0 recorded in 2022.
  • Peak annual rise in Tax Provisions hit 7400.0% in 2023, while the deepest fall reached 3318.52% in 2023.
  • Over 3 years, Tax Provisions stood at $27000.0 in 2022, then crashed by 3318.52% to -$869000.0 in 2023, then soared by 304.37% to $1.8 million in 2024.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $1.8 million, -$8000.0, and $22000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.